Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group

Autor:	Papageorgiou, S.G. Kotsianidis, I. Kontos, C.K. Symeonidis, A. Galanopoulos, A. Hatzimichael, E. Poulakidas, E. Diamantopoulos, P. Vassilakopoulos, T.P. Zikos, P. Papadaki, H. Bouronikou, E. Panayiotidis, P. Viniou, N.-A. Pappa, V.
Jazyk:	angličtina
Rok vydání:	2018
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______2127::8685838cc84852a40edd9b7358bee096 https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3087480 Zobrazit plný text záznamu